The Senate Finance Committee is crafting bipartisan legislation to tackle drug shortages that it says may include Medicare payment changes, reforms to stabilize the supply of generic sterile injectables (GSIs), incentives for hospitals and pharmacies to procure generic drugs based on quality, reliability and sustainable contracts, and reforms to the Medicaid Drug Rebate Program. A framework for the bipartisan legislation, unveiled Thursday (Jan. 25), includes revamping contracts between hospitals, group purchasing organizations and GSI manufacturers. The move comes after industry...